Virinchi Limited — Board Meeting, 14-08-2025: Outcome of Board Meeting

Virinchi's board has approved the consolidated financial results for the quarter ended June 30, 2025. The board also discussed strategic options for its high EBITDA Fin-Tech SaaS unit, "QFund." Plans include restructuring QFund into a 100% subsidiary via a slump sale to create a focused entity and unlock shareholder value. They are also looking to divest a portion of QFund through private investment, strategic partnerships, or an IPO. The funds raised would be used to reduce company debt and expand the Virinchi hospital chain's oncology healthcare vertical. A follow-up board meeting is scheduled for August 22, 2025, to further discuss these strategic moves.